Acorda Therapeutics Inc
NASDAQ:ACOR
Acorda Therapeutics Inc
Other Operating Expenses
Acorda Therapeutics Inc
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Acorda Therapeutics Inc
NASDAQ:ACOR
|
Other Operating Expenses
$4.5m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Operating Expenses
$169m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Operating Expenses
-$791m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Operating Expenses
$49.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Operating Expenses
-$13.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Acorda Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
4.5m
USD
Based on the financial report for Dec 31, 2023, Acorda Therapeutics Inc's Other Operating Expenses amounts to 4.5m USD.
What is Acorda Therapeutics Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
-55%
Over the last year, the Other Operating Expenses growth was -67%. The average annual Other Operating Expenses growth rates for Acorda Therapeutics Inc have been -55% over the past three years .